110 related articles for article (PubMed ID: 14967092)
41. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
42. Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension.
Turgut Cosan D; Colak E; Saydam F; Yazıcı HU; Degirmenci I; Birdane A; Colak E; Gunes HV
Clin Exp Hypertens; 2016; 38(7):602-607. PubMed ID: 27668323
[TBL] [Abstract][Full Text] [Related]
43. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
44. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
Rios DL; D'Onofrio LO; Cerqueira CC; Bonfim-Silva R; Carvalho HG; Santos-Filho A; Galvão-Castro B
Clin Chem Lab Med; 2007; 45(7):874-8. PubMed ID: 17617030
[TBL] [Abstract][Full Text] [Related]
45. The effect of the paraoxonase 1 (PON1) T(-107)C polymorphism on serum PON1 activity in women is dependent on fatty acid intake.
Santos FG; Becker MK; Corrêa VS; Garcia DN; Vale SC; Crespo-Ribeiro JA; Barros CC; Schneider A
Nutr Res; 2016 Jan; 36(1):9-15. PubMed ID: 26773776
[TBL] [Abstract][Full Text] [Related]
46. Paraoxonase 1 serum activity in women: the effects of menopause, the C(-107)T polymorphism and food intake.
Ritta MC; Baldez AM; Oliveira IO; Garcia DN; Souza PS; Andrade KRDS; Valle SC; Pieniz S; Barros CC; Masternak MM; Schneider A
Arch Endocrinol Metab; 2019; 63(3):272-279. PubMed ID: 31038597
[TBL] [Abstract][Full Text] [Related]
47. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
[TBL] [Abstract][Full Text] [Related]
48. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
49. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
50. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
51. Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
Fu R; Sun YM; Su Y; Wu Y; Luan Y
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):982-3. PubMed ID: 18430057
[TBL] [Abstract][Full Text] [Related]
52. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
[TBL] [Abstract][Full Text] [Related]
53. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
54. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux.
Gaidukov L; Rosenblat M; Aviram M; Tawfik DS
J Lipid Res; 2006 Nov; 47(11):2492-502. PubMed ID: 16914770
[TBL] [Abstract][Full Text] [Related]
55. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
Atar A; Gedikbasi A; Sonmezay E; Kiraz ZK; Abbasoglu S; Tasci AI; Tugcu V
Ren Fail; 2016; 38(3):378-82. PubMed ID: 26795139
[TBL] [Abstract][Full Text] [Related]
56. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
57. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
58. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
[TBL] [Abstract][Full Text] [Related]
59. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
[TBL] [Abstract][Full Text] [Related]
60. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.
Deakin S; Moren X; James RW
Atherosclerosis; 2005 Mar; 179(1):17-25. PubMed ID: 15721005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
